-
Mashup Score: 0Racial and Ethnic Disparities in Biologic Prescriptions for Asthma in the United States - 2 year(s) ago
Article InfoPublication HistoryAccepted: August 2, 2022Received in revised form: July 30, 2022Received: April 29, 2022Publication stageIn Press Journal Pre-ProofFootnotesConflicts of Interests: T.A.-S. has patents pending for MicroRNAs as Predictors of Response to Anti-IgE Therapies in Chronic Spontaneous Urticaria as well as…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0Phase I/II Study of Topical Biologic Shows Positive Results for the Treatment of Basal Cell Carcinoma - 2 year(s) ago
MW005 treatment for low-risk basal cell carcinoma would offer patients an alternative to surgical excision.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
MW005, a topical #biologic for the treatment of basal cell carcinoma, may offer patients an alternative option to surgical excision. #BCC https://t.co/BUA3C0dgyF
-
-
Mashup Score: 1
Growth in new biologic treatments for widespread cutaneous disease along with innovation in medications for rare conditions such as generalized pustular psoriasis have moved infusion therapy from a nice-to-know to a need-to-know point on dermatologists’ continuing learning curve. The National Infusion Center Association provides answers to commonly asked questions about biologics in an…
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
Nicholas Brownstone, MD, discusses what dermatologists need to know about #biologic treatments. The National Infusion Center Association also developed an informative presentation, BIOLOGICS 101, to answer commonly asked questions. #NICA https://t.co/1KhJrhRO87
-
-
Mashup Score: 2Biologic Use and Outcomes Among Adults with Severe Asthma Treated by United States Subspecialists - PubMed - 2 year(s) ago
Real-world starting and switching of biologic therapies for SA was associated with meaningful reductions in exacerbations. With increasing biologic options available, individualized approaches to therapy may improve patient outcomes.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
#Biologic Use and Outcomes Among #Adults with #Severe #Asthma Treated by United States Subspecialists https://t.co/YBJhUHkqVB https://t.co/8MFcKOLSKH
-
-
Mashup Score: 1
While the long-term efficacy and safety of the biologic has been investigated in, few studies have been based on real life experience.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
"We can consider ixekizumab as a safe inhibitor of IL-17 characterized by a rapid clinical response, but also with a long-term efficacy observed by randomized clinical trials and confirmed by our real-life experience." #biologic #psoriasis https://t.co/xXovmWOguj
-
-
Mashup Score: 0
Investigators suggested that the large number of systemic therapies used when treating HS in these patients indicated referral delays or difficulties in obtaining disease control in those with moderate to severe HS.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
A new study found that patients with moderate to severe hidradenitis suppurativa were treated with up to 5 different systemic therapies before being prescribed #biologic therapy. #dermtwitter https://t.co/PL9PC0cLHr
-
-
Mashup Score: 0EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases - 2 year(s) ago
Objective To develop EULAR points-to-consider for therapeutic drug monitoring (TDM) of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases (RMDs). Methods The points-to-consider were developed in accordance with EULAR standardised operation procedures by a multidisciplinary task force from eight European countries, based on a systematic literature review and expert…
Source: Annals of the Rheumatic DiseasesCategories: Latest Headlines, RheumatologyTweet-
Do you consider drug monitoring in your patients with #RMDs? @eular_org task force has now published on what to consider for therapeutic #drug monitoring of biopharmaceuticals https://t.co/PJuznWuzb5 #DMARDs #trials #biologic @ProfJohnIsaacs https://t.co/7zSQvObm7k
-
-
Mashup Score: 0An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes - 2 year(s) ago
Treatment of hypereosinophilic syndrome (HES) often requires the use of immunomodulators with substantial side effect profiles. The emergence of biologics offers an alternative treatment modality.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue (Free)! An International, Retrospective Study of #Off- #Label #Biologic Use in the Treatment of #Hypereosinophilic #Syndromes https://t.co/GdYY4m8cj0 https://t.co/Act0YYVIzF
-
-
Mashup Score: 2Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma - 2 year(s) ago
Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine.
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Global #Variability in #Administrative #Approval #Prescription #Criteria for #Biologic #Therapy in #Severe #Asthma https://t.co/2voNVdMt8R https://t.co/AA6fHk2oMb
-
-
Mashup Score: 0Dr Elaine Siegfried on Considerations for Systemic Therapy Use in Pediatric Atopic Dermatitis - 2 year(s) ago
Elaine Siegfried, MD, professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, discusses several pediatric patient populations with atopic dermatitis who are candidates for the use of systemic therapies.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Watch our interview with Dr Elaine Siegfried of @SLUHospital as she discusses considerations for systemic therapy use in pediatric #AtopicDermatitis. #biologic https://t.co/h0G38R6O42 https://t.co/zzTKj6CYAA
-
In Press! #Racial and #Ethnic #Disparities in #Biologic #Prescriptions for #Asthma in the United States https://t.co/NDZCuKzO3X